BIONIK
  • Solutions
    • InMotion® Therapy
    • InMotion® ARM
    • InMotion® ARM/HAND
    • InMotion® EVAL
    • InMotion® Connect
    • InMotion® for PT
    • InMotion® for OT
  • Evidence
    • Featured Webinars
    • Testimonials
    • Published Research
    • Clinical Guidelines
  • Blog
  • News
    • Media Coverage
    • Press Releases
  • Events
    • Conferences
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Investors
    • Careers
    • Contact
Select Page

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Press Releases
  • IR Calendar
  • Email Alerts

Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors

Sep 13, 2018

Bionik Laboratories Reports First Quarter Fiscal 2019 Financial Results

Aug 14, 2018

Bionik Laboratories Reports Fiscal Year 2018 Financial Results

Jun 27, 2018

Bionik Laboratories Announces Agreement with The Transitional Learning Center for InMotion Arm Robotic Systems

Jun 21, 2018

Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer

Jun 11, 2018

Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System

May 16, 2018

Bionik Laboratories Issues Letter to Stockholders

Apr 3, 2018

Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors

Mar 20, 2018

Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea

Mar 7, 2018

Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results

Feb 13, 2018
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12

    Clinical Evidence

    • About
    • Investors
    • Disclaimer
    • Privacy Policy

    News + Events

    • Recent News
    • Events
    • Press Releases

    Support

    • Contact Us
    • Cleaning Procedures
    Global Headquarters

    80 Coolidge Hill Road
    Watertown, MA 02472
    United States
    Tel: +1 617.926.4800
    support@bioniklabs.com
    ©2022 BIONIK